RFA-AI-28-014-Full-Announcement.html

HTML file 222 KB Posted

Attached to
Systems Biology of Infection and Inflammation in Chronic Diseases (U19 Clinical Trial Not Allowed)
Opportunity number
RFA-AI-28-014
Issued by

About this file

This is a Request for Application (RFA) announcing a federal cooperative agreement funding opportunity titled "Systems Biology of Infection and Inflammation in Chronic Diseases (U19 Clinical Trial Not Allowed)," issued by the National Institutes of Health with participation from nine institutes and centers: NIAID, NEI, NHLBI, NHGRI, NIA, NIAMS, and NIDCR. The funding opportunity (FON RFA-AI-28-014) seeks to support multidisciplinary, multi-institutional research centers using systems biology approaches to understand links between infectious pathogens, inflammatory pathways, and chronic diseases through integration of clinical data, omics datasets, artificial intelligence, and computational modeling. The announcement was posted November 4, 2026, with an open date of January 18, 2027, and application deadline of February 19, 2027, at 5:00 PM local time. The earliest start date is February 18, 2027, with scientific merit review and advisory council review anticipated for July and October 2027, respectively, and awards expected in January 2028.

Two types of centers are supported: Chronic and Infectious Diseases Systems Biology Centers (CIDSB) and Systems Biology Inflammation Centers (SBI). Total anticipated funding is $25.5 million to support 6–9 awards, with NIAID committing $18.5 million for 5–6 CIDSB awards; NIA and NIAMS committing $6 million for 1–2 SBI awards; NIDCR contributing up to $1 million; and NEI contributing $500,000 annually for eye-imaging integrated data. CIDSB center budgets cannot exceed $2.5 million in direct costs annually, while SBI center budgets must align with project needs with no stated cap. All awards are for five-year project periods. Eligible applicants include higher education institutions (public and private), nonprofits with and without 501(c)(3) status, for-profit organizations and small businesses, state and local governments, tribal governments, and faith-based or community-based organizations; non-domestic entities and foreign subawards/subcontracts are not eligible except where specifically designated for international collaboration. Applications must follow multi-project (M) instructions and include an Overall component, Administrative Core, Data and Modeling Core, Biospecimen Collection and Processing Core, two to three Research Projects, and optional Technology Development Core and Validation and Translation Core, with specific page limits for each component. All Program Directors/Principal Investigators must register with eRA Commons, obtain ORCID identifiers, and complete SAM and Grants.gov registrations prior to submission.

RFA-AI-28-014-Full-Announcement.html

Text of this file

Department of Health and Human Services

Part 1. Overview Information

Participating Organization(s)

National Institutes of Health (NIH)

Components of Participating Organizations

National Institute of Allergy and Infectious Diseases (NIAID)

National Eye Institute (NEI)

National Heart, Lung, and Blood Institute (NHLBI)

National Human Genome Research Institute (NHGRI)

National Institute on Aging (NIA)

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

National Institute of Dental and Craniofacial Research (NIDCR)

All applications to this funding opportunity announcement should fall within the mission of the Institutes/Centers. The following NIH Offices may co-fund applications assigned to those Institutes/Centers.

Office of Research on Women's Health (ORWH)

Office of Data Science Strategy (ODSS)

Note: Not all NIH Institutes, Centers, and Offices (ICOs) participate in Announcements. Applicants should carefully note which ICOs participate in this announcement and view their respective areas of research interest at the ICO-Specific Scientific Interests website. ICOs that do not participate in this announcement will not consider applications for funding.

Funding Opportunity Title

Systems Biology of Infection and Inflammation in Chronic Diseases (U19 Clinical Trial Not Allowed)

Activity Code

U19 Research Program – Cooperative Agreements

Announcement Type

New

Related Notices

Check for any recent Notices of NIH Policy Changes that may impact application requirements.
January 23, 2026 - NIH Pause on New Submissions to the NIH Human Embryonic Stem Cell Registry and Request for Information on Reducing Reliance on Human Embryonic Stem Cells in NIH-Supported Research. See Notice, NOT-OD-26-031.

Funding Opportunity Number (FON)

RFA-AI-28-014

Companion Notice of Funding Opportunity

None

Number of Applications

See Section III. 3. Additional Information on Eligibility.

Assistance Listing Number(s)

93.8RP, 93.8TD, 93.8AM, 93.543, 93.AGR, 93.172, 93.121, 93.HL2, 93.AR1, 93.ADR, 93.DSS

Notice of Funding Opportunity Purpose

The purpose of this notice of funding opportunity (NOFO) is to support the advancement of systems-level understanding of the link between infectious pathogens and inflammatory pathways that result in predisposition, onset and progression of chronic diseases. The NOFO will stimulate integration of clinical and patient data, large-scale omics datasets, advanced Artificial Intelligence (AI) and computational modeling to prevent, treat, and mitigate the combined impact of chronic diseases, inflammation, and infections.

Funding Opportunity Goal(s)

NIH's mission is to seek fundamental knowledge about the nature and behavior of living systems and the application of that knowledge to enhance health, lengthen life, and reduce illness and disability.

Key Dates

Posted Date

November 04, 2026

Open Date (Earliest Submission Date)

January 18, 2027

Application Due Dates
Review and Award Cycles
New
Renewal / Resubmission / Revision (as allowed)
AIDS - New/Renewal/Resubmission/Revision, as allowed
Scientific Merit Review
Advisory Council Review
Earliest Start Date

February 18, 2027

Not Applicable

Not Applicable

July 2027
October 2027

January 2028

All applications are due by 5:00 PM local time of applicant organization.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Expiration Date

February 19, 2027

Due Dates for E.O. 12372

Not Applicable

Required Application Instructions

It is critical that applicants follow the Multi-Project (M) Instructions in the How to Apply - Application Guide, except where instructed to do otherwise (in this NOFO or in a Notice from the NIH Guide for Grants and Contracts). Conformance to all requirements (both in the How to Apply - Application Guide and the NOFO) is required and strictly enforced. Applicants must read and follow all application instructions in the How to Apply - Application Guide as well as any program-specific instructions noted in Section IV. When the program-specific instructions deviate from those in the How to Apply - Application Guide, follow the program-specific instructions. Applications that do not comply with these instructions may be delayed or not accepted for review.

There are several options available to submit your application through Grants.gov to NIH and Department of Health and Human Services partners. You must use one of these submission options to access the application forms for this opportunity.
Use the NIH ASSIST system to prepare, submit and track your application online.
Use an institutional system-to-system (S2S) solution to prepare and submit your application to Grants.gov and eRA Commons to track your application. Check with your institutional officials regarding availability.

Table of Contents

Part 1. Overview Information Key Dates Part 2. Full Text of Announcement Section I. Notice of Funding Opportunity Description Section II. Award Information Section III. Eligibility Information Section IV. Application and Submission Information Section V. Application Review Information Section VI. Award Administration Information Section VII. Agency Contacts Section VIII. Other Information

Part 2. Full Text of Announcement

Section I. Notice of Funding Opportunity Description

Research Objectives Critical gaps remain in understanding the links among acute and chronic infections, microbiome alterations, inflammation, and chronic diseases. To address these gaps, this notice of funding opportunity (NOFO) will support system biology studies that leverage existing longitudinal patients cohorts, metadata (e.g., primary care, health systems, and electronic health records [EHRs]) and multiomics datasets; integrate high-throughput molecular and clinical data; apply advanced Artificial Intelligence (AI) and computational modeling; and focus on validating and translating findings through laboratory studies, including new approach methodologies (NAMs) and animal models, as well as analysis of real-world data (RWD). The long-term scientific goals of this NOFO will be achieved by establishing Centers that will be focused either on the links between chronic and infectious diseases (Chronic and Infectious Diseases Systems Biology Centers) or on the role(s) of inflammation in chronic diseases (Systems Biology Inflammation Centers).

The research activities supported by this NOFO will enable:

Multiscale, multiomic insights across multiple diseases that can result in new disease classifications.
Discovery of novel drug target and biomarkers across chronic diseases.
Development of diagnostic biomarkers for disease risk, progression and severity.
Rational design of combination therapies and biomarkers of efficacy and toxicity.
Harmonized cross disease datasets and data framework that embrace Findable, Accessible, Interoperable, and Reproducible (FAIR) principles.

Chronic and Infectious Diseases Systems Biology Center (CIDSB) Centers that study the link between chronic and infectious diseases will support innovative research on a broad spectrum of chronic diseases that may either result from an infection, or contribute to, enhance susceptibility, or exacerbate infections. These could include but are not limited to disorders of immune modulation and inflammation (e.g. inflammatory bowel disease (IBD), cancer, neurological diseases, cardiovascular disease, metabolic disorders (e.g. diabetes, obesity), and mental health disorders). The CIDSB Centers are envisioned to encompass a range of infections of high relevance in the United States, including but not limited to Lyme, influenza, respiratory syncytial virus, tuberculosis, Epstein Barr Virus, among other, recurring or persistent infections such as but not limited to pneumonia or urinary tract infections. The CIDSB Centers could support data collection from prospective infection cohorts to a limited degree to ensure sufficient data is available for model development and validation.

Specific Areas of Research Interest include but are not limited to those listed below:

Use of existing cohorts, EHRs, and RWD, including people with chronic diseases and those with infectious diseases who develop post-acute symptoms.
Determination of host/pathogen, microbiome, genetic and epigenetic biosignatures in response to infection and/or chronic disease, identify signatures associated with preventing negative outcomes, or with successful therapeutic intervention.
Determination of whether and how timing of exposure across the lifespan to infections and antibiotics influence chronic diseases risk and outcomes in different populations.

Systems Biology Inflammation Center (SBI) Centers that study the link between inflammation and chronic diseases will support innovative research on the role of inflammation in chronic diseases, specifically those already studied in the Accelerating Medicines Partnership® (AMP®) and related NIH programs. The Centers will continue to build on a common goal of deconstructing the complex biology of chronic diseases with multidimensional data to accelerate the discovery of novel targets and biomarkers. The SBI Centers will enable a systems biology approach to identify shared and distinct, causal, immune/inflammatory mechanisms across chronic diseases to accelerate the discovery of novel, precision medicine, targets and biomarkers.

Specific Areas of Research Interest include but are not limited to those listed below:

Increase the interoperability among relevant AMP data and fill-in critical data gaps by bringing external datasets and new data generation.
Build predictive models of inflammation/immune dysregulation common and specific to diseases and disease stages.
Identify inflammatory/immune signatures of disease across target and peripheral tissues.

Center Organization The overall structure of the Center is designed to support multidisciplinary, multi-institutional research teams in the conduct of their Research Projects, integrating dedicated Cores for biospecimen collection, multiomics analyses, and advanced AI and computational modeling.

Administrative Core: Responsible for managing, coordinating, and supervising the Center research and outreach activities, monitoring progress, participation in systems-biology Consortium-wide working groups, and ensuring that the overall project management plan is implemented effectively and within proposed timelines. One SBI recipient, selected by NIH, will be responsible for managing an Opportunities Funds for Collaborative Projects for the entire SBI program.

Data and Modeling Core: Responsible for development, maintenance, storage, management and dissemination of datasets, analytical tools, computational models, reagents, and other resources generated by the Center in a secure manner.

Technology Development Core: If proposed, responsible for supporting and developing high-throughput technologies for systems biology analyses of clinical samples, including omics platforms such as genomics, transcriptomics, proteomics, metabolomics, lipidomics, methylomics, and microbiome profiling, as well as other advanced high throughput approaches.

Validation and Translation Core: If proposed, responsible for supporting essential platforms to assess model precision and reproducibility to validate the findings from the Research Projects and Cores, including predictive models, biomarkers, and predicted candidate interventions. This Core serves as a critical bridge between systems-level discoveries and clinical applications thereby improving patient stratification, and advancing the development of diagnostics, therapeutics, and prevention approaches.

Biospecimen Collection and Processing Core: Responsible for establishing the study cohort including potential recruitment and obtaining participant consent and/or interacting with the AMP program. Responsible for collection and processing of samples relevant to the proposed chronic illness, inflammation and/or acute infections according to the proposed Center.

Research Projects: Centers will be organized around two to three Research Projects aligned with the overall Center goals of research on inflammation, pathogens, microbiome, and/or chronic diseases. Research Projects exploring hypothesis-driven research will be able to identify, quantify, model, and predict the interaction networks among inflammation and/or targeted pathogens, the microbiome, and host cells to understand chronic disease.

Collaborative Interdisciplinary Teams and Outreach Centers may span one or multiple institutions. CIDSB and SBI Centers will collaborate with each other as the CIDSB and SBI Consortia, respectively. The goals of CIDSB and SBI Consortia will be to improve the use of shared protocols, technologies, and data, enhance reproducibility, and coordinate outreach efforts promoting systems biology approaches to infectious, inflammatory, microbiome-related, and chronic diseases.

Scientific Advisory Group: A Consortium-wide Scientific Advisory Group (SAG) will be established by NIH in collaboration with the recipients. The SAG will assist in reviewing research productivity, progress toward the proposed goals, adherence to timelines, and the continued relevance of the research approach. Do not list names of possible SAG members in the application or contact potential members prior to award.

Applications Not Responsive to this NOFO The following types of applications are not responsive to this NOFO and will not be reviewed:

Applications that do not use material from longitudinal human clinical samples (e.g. human cells or tissues, human blood, immune components, bacterial isolates) with clinical data.
Applications that focus exclusively on the molecular interaction networks of the pathogen with no consideration of those in the host.
Applications that focus solely on development of computational and software tools for "big-data" integration.
Studies on HIV/AIDS.

Applicants are encouraged to contact the Scientific/Research Contacts to discuss their application prior to submission of their application.

See Section VIII. Other Information for award authorities and regulations.

Section II. Award Information

Funding Instrument

Cooperative Agreement: A financial assistance mechanism used when there will be substantial Federal scientific or programmatic involvement. Substantial involvement means that, after award, NIH scientific or program staff will assist, guide, coordinate, or participate in project activities. See Section VI.2 for additional information about the substantial involvement for this NOFO.

Application Types Allowed

New

The OER Glossary and the How to Apply - Application Guide provides details on these application types. Only those application types listed here are allowed for this NOFO.

Clinical Trial?

Not Allowed: Only accepting applications that do not propose clinical trials.

Need help determining whether you are doing a clinical trial?

Funds Available and Anticipated Number of Awards

The following NIH components intend to commit the following amounts in FY 2028:

NIAID intends to commit a total of $18.5 million to fund 5 - 6 awards for Chronic and Infectious Diseases System Biology Centers.

NIA and NIAMS intend to commit a total of $6 million to fund 1 - 2 System Biology Inflammation Center awards.

NIDCR intends to commit a total of up to $1M for projects within NIDCR mission.

NEI intends to commit a total of $500,000 per year to fund eye-imaging integrated data.

Award Budget

Application budgets for CIDSB Center applications are not expected to exceed $2.5 million in direct costs per year. Applications budgets for SBI Center applications are not capped but must align with the actual needs of the project. For all Center applications, the budget must reflect the actual needs of the proposed project.

Award Project Period

The project period must be 5 years.

NIH grants policies as described in the NIH Grants Policy Statement will apply to the applications submitted and awards made from this NOFO.

Section III. Eligibility Information

1. Eligible Applicants

Eligible Organizations

Higher Education Institutions - Includes all types
Public/State Controlled Institutions of Higher Education
Private Institutions of Higher Education

Nonprofits Other Than Institutions of Higher Education

Nonprofits with 501(c)(3) IRS Status (Other than Institutions of Higher Education)
Nonprofits without 501(c)(3) IRS Status (Other than Institutions of Higher Education)

For-Profit Organizations

Small Businesses
For-Profit Organizations (Other than Small Businesses)

Local Governments

State Governments
County Governments
City or Township Governments
Special District Governments
Indian/Native American Tribal Governments (Federally Recognized)
Indian/Native American Tribal Governments (Other than Federally Recognized)

Federal Governments

Eligible Agencies of the Federal Government

U.S. Territory or Possession

Other

Independent School Districts

Public Housing Authorities/Indian Housing Authorities

Native American Tribal Organizations (other than Federally recognized tribal governments)

Faith-based or Community-based Organizations

Regional Organizations

Foreign Organizations/International Collaborations

Non-domestic (non-U.S.) Entities (Foreign Organization) are not eligible to apply.

Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.

Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

NIH will no longer issue awards (i.e., new, renewal, or non-competing continuation) to domestic or foreign entities that involve foreign subawards/subcontracts. All NIH-funded research involving foreign subawards/subcontracts must be submitted in response to a NOFO that is specifically designated for funded international collaborations. See NIH Grants Policy Statement 16.8 Collaborative International Research Awards.

Applications involving foreign subawards/subcontracts submitted in response to this NOFO will be deemed noncompliant and will not be considered for funding. This policy applies to all monetary international collaborations resulting in foreign subawards/subcontracts, however, it does not preclude unfunded international collaborations or foreign components, funding for foreign consultants, or procurement of unique equipment or supplies from foreign vendors.

Required Registrations

Applicant organizations Applicant organizations must complete and maintain the following registrations as described in the How to Apply- Application Guide to be eligible to apply for or receive an award. All registrations must be completed prior to the application being submitted. Registration can take 6 weeks or more, so applicants should begin the registration process as soon as possible. Failure to complete registrations in advance of a due date is not a valid reason for a late submission, please reference NIH Grants Policy Statement Section 2.3.9.2 Electronically Submitted Applications for additional information.

System for Award Management (SAM) – Applicants must complete and maintain an active registration, which requires renewal at least annually. The renewal process may require as much time as the initial registration. SAM registration includes the assignment of a Commercial and Government Entity (CAGE) Code for domestic organizations which have not already been assigned a CAGE Code. Foreign organizations must obtain a NATO Commercial and Government Entity (NCAGE) Code (in lieu of a CAGE code) in order to register in SAM. Unique Entity Identifier (UEI)- A UEI is issued as part of the SAM.gov registration process. The same UEI must be used for all registrations, as well as on the grant application.

eRA Commons - Once the unique organization identifier is established, organizations can register with eRA Commons in tandem with completing their Grants.gov registration; all registrations must be in place by time of submission. eRA Commons requires organizations to identify at least one Signing Official (SO) and at least one Program Director/Principal Investigator (PD/PI) account in order to submit an application.
Grants.gov – Applicants must have an active SAM registration in order to complete the Grants.gov registration.

Program Directors/Principal Investigators (PD(s)/PI(s)) All PD(s)/PI(s) must have an eRA Commons account. PD(s)/PI(s) should work with their organizational officials to either create a new account or to affiliate their existing account with the applicant organization in eRA Commons. If the PD/PI is also the organizational Signing Official, they must have two distinct eRA Commons accounts, one for each role. Obtaining an eRA Commons account can take up to 2 weeks.

All PD(s)/PI(s) must be registered with ORCID. The personal profile associated with the PD(s)/PI(s) eRA Commons account must be linked to a valid ORCID ID. For more information on linking an ORCID ID to an eRA Commons personal profile see the ORCID topic in our eRA Commons online help.

Eligible Individuals (Program Director/Principal Investigator)

Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) is invited to work with his/her organization to develop an application for support.

For institutions/organizations proposing multiple PDs/PIs, visit the Multiple Program Director/Principal Investigator Policy and submission details in the Senior/Key Person Profile (Expanded) Component of the How to Apply - Application Guide.

2. Cost Sharing This NOFO does not require cost sharing as defined in the NIH Grants Policy Statement Section 1.2- Definitions of Terms.

3. Additional Information on Eligibility Number of Applications

Applicant organizations may submit more than one application, provided that each application is scientifically distinct.

The NIH will not accept duplicate or highly overlapping applications under review at the same time per NIH Grants Policy Statement Section 2.3.7.4 Submission of Resubmission Application. This means that the NIH will not accept:

A new (A0) application that is submitted before issuance of the summary statement from the review of an overlapping new (A0) or resubmission (A1) application.

A resubmission (A1) application that is submitted before issuance of the summary statement from the review of the previous new (A0) application.

An application that has substantial overlap with another application pending appeal of initial peer review (see NIH Grants Policy Statement 2.3.9.4 Similar, Essentially Identical, or Identical Applications).

Section IV. Application and Submission Information

1. Requesting an Application Package The application forms package specific to this opportunity must be accessed through ASSIST or an institutional system-to-system solution. A button to apply using ASSIST is available in Part 1 of this NOFO. See the administrative office for instructions if planning to use an institutional system-to-system solution.

2. Content and Form of Application Submission It is critical that applicants follow the Multi-Project (M) Instructions in the How to Apply - Application Guide, except where instructed in this notice of funding opportunity to do otherwise (in this NOFO, in a policy notice, or other notice from NIH Guide for Grants and Contracts) and where instructions in the How to Apply - Application Guide are directly related to the Grants.gov downloadable forms currently used with most NIH opportunities. Conformance to the requirements in the How to Apply - Application Guide is required and strictly enforced. Applications that are out of compliance with these instructions may be delayed or not accepted for review.

Page Limitations All page limitations described in the How to Apply- Application Guide and the Table of Page Limits must be followed.

Component
Component Type for Submission
Page Limit
Required/Optional
Minimum
Maximum
Overall
Overall
12

Required

1
1
Administrative Core
Admin Core
6

Required

Data and Modeling Core
DM Core
12

Required

Technology Development Core
TD Core
6

Optional

Validation and Translation Core
VT Core
12

Optional

Biospecimen Collection and Processing Core
BCP Core
6

Required

Research Projects
Project
12

Required

Instructions for the Submission of Multi-Component Applications

The following section supplements the instructions found in How to Apply- Application Guide and should be used for preparing a multi-component application.

The application should consist of the following components:
Overall: required, 1
Administrative Core: required, 1
Data and Modeling Core: required, 1
Technology Development Core: required for CIDSB, 1; optional for SBI
Validation and Translation Core: required for CIDSB, 1; optional for SBI
Biospecimen Collection and Processing Core: required, 1
Research Projects: required 3 for CIDSB; minimum 2 for SBI

Overall Component When preparing the application, use Component Type 'Overall'.

All instructions in the How to Apply - Application Guide must be followed, with the following additional instructions, as noted.

SF424(R&R) Cover (Overall) Complete entire form.

PHS 398 Cover Page Supplement (Overall)

Note: Human Embryonic Stem Cell lines from other components should be repeated in cell line table in Overall component.

Research & Related Other Project Information (Overall) Follow standard instructions.

Project/Performance Site Locations (Overall) Enter primary site only.

A summary of Project/Performance Sites in the Overall section of the assembled application image in eRA Commons compiled from data collected in the other components will be generated upon submission.

Research and Related Senior/Key Person Profile (Overall) Include only the Project Director/Principal Investigator (PD/PI) and any multi-PDs/PIs (if applicable to this NOFO) for the entire application.

A summary of Senior/Key Persons followed by their Biographical Sketches in the Overall section of the assembled application image in eRA Commons will be generated upon submission.

Budget (Overall) The only budget information included in the Overall component is the Estimated Project Funding section of the SF424 (R&R) Cover.

A budget summary in the Overall section of the assembled application image in eRA Commons compiled from detailed budget data collected in the other components will be generated upon submission.

PHS 398 Research Plan (Overall)

Specific Aims: List in priority order, the broad, long-range objectives and goals of the proposed Systems Biology Center. Describe the hypothesis or hypotheses to be tested.

Research Strategy: Applications submitted in response to this NOFO must be primarily aligned with the goals and objectives of only one type of Center, therefore applications should clearly state the type of Center (CIDSB or SBI) being established. Provide an overview of the Center's organizational structure, scientific focus, and overarching objectives. Describe how the proposed Research Projects and Cores will work together to apply systems biology approaches to understand the linkages among infectious diseases, the microbiome, inflammation, and chronic diseases, depending on which type of Center is proposed.
Describe how the individual Research Projects and Cores relate to the overall goals of the Center and provide a cohesive and synergistic whole.
Describe how the multi-disciplinary Centers leverage unique research resources and patient populations to advance understanding of the type of Center selected.
Describe how the individual Research Projects and Cores leverage systems approaches that will improve the ability to develop and use predictive computational models (e.g.: disease onset, progression and exacerbation; disease severity; and/or identify candidate targets for interventions).
Describe how the individual Research Projects and Cores will enable predictive model implementation and subsequent use of modeling approaches more broadly, including validation, translation and/or implementation in the clinic.
Clearly define the approach for dissemination, validation, and implementation of Center outputs, such as models that stratify patients by risk, or forecast disease symptoms or patient outcomes that adhere to FAIR principles and toward a vision of federated learning.
Define a timeline and benchmarks plan that clearly articulates Center activities on a yearly basis.
Describe how the Center plans to complete any enrollment and the bulk of specimen collection within the first two to three years, make progress towards early data integration within the first three years, and conduct a majority of analysis, modeling, validation, and dissemination during the remaining two years.
Describe plans for ongoing analysis, modeling, validation, and dissemination and intermediate benchmarks for those activities.

For CIDSB, describe:

Whether the Center will focus on a single or a variety of different infectious and chronic diseases to address the Program objectives. It is not necessary for Centers to only study a single infectious and/or chronic disease.
How the Center will include research objectives to explore both aspects of the interactions between infectious and chronic diseases that lead to worse outcomes. For example, research projects could focus on the mechanisms of increased susceptibility to a particular infection due to an underlying chronic illness; others could focus on how a different infectious disease results in chronic or post-acute sequalae; or research on worsening outcomes and susceptibilities that result from combinations of infectious and chronic illnesses over time.

For SBI, describe:

How the Center will include data and specimens from the AMP program, including Alzheimer's Disease (AMP AD 1.0 and AMP AD 2.0), Rheumatoid Arthritis and Systemic Lupus Erythematosus (AMP RA/SLE), Autoimmune and Immune-Mediated Diseases (AMP AIM), Common Metabolic Diseases (AMP CMD), Parkinson's Disease (AMP PD), Type 2 Diabetes (AMP T2D), Parkinson's Disease and Related Disorders (AMP PDRD).
How the Center will fill in critical multi-omic (bulk and single cell) data gaps using existing biosamples from the various cohorts and biobanks affiliated with the AMP program.
How the Center will conduct harmonization of compatible cross-disease datasets and distribution of newly generated data, systems biology data models and other analytical outputs.
How the Center will leverage multidimensional data from three or more chronic diseases across the following chronic disease groups: autoimmune, cardiometabolic, neurodegenerative and neuropsychiatric (among the selected diseases one must be neurodegenerative and one must be autoimmune).
How the Center will establish a multiscale analysis framework that will use existing and develop new computational tools (including AI/ML approaches) to conduct a series of cross-disease systems biology analyses aimed at addressing scientific questions with high translational value.

Letters of Support: Provide letters of support providing evidence of institutional support and commitment, as well as access to critical facilities, equipment, resources, biospecimens, or collaborations.

Resource Sharing Plan:

Individuals are required to comply with the instructions for the Resource Sharing Plans as provided in the How to Apply - Application Guide.

Other Plan(s):

All instructions in the How to Apply- Application Guide must be followed, with the following additional instructions:

A Data Management and Sharing Plan (DMS Plan) is required for any NIH-funded or conducted research that will generate scientific data. Applicants must submit the DMS Plan at the time of application using the NIH DMS Plan Format Page. The DMS Plan must address the elements in the structured format. Where the DMS Plan Format Page requires a "Yes or No" response, no additional narrative is allowed. The Data Management and Sharing (DMS) Plan must be provided in the Overall component.
Recipients must use NIH-approved data repositories (https://grants.nih.gov/policy-and-compliance/policy-topics/sharing-policies/dms) that may include but are not limited to ImmPort, Bioinformatics Resource Centers (BRCs), mapMECFS, Immune Epitope Database (IEDB), Accessing NIAID Clinical Trails Data etc. Recipients may further disseminate data, results, and analyses through other established repositories, and/or work with their institutional library-supported repository to self-publish all useful and usable data as a foundation for further study. Dissemination in NIH-supported repositories enables indexing and discoverability through the NIAID Data Ecosystem (NDE).

Appendix:

Only limited items are allowed in the Appendix. Follow all instructions for the Appendix as described in How to Apply- Application Guide; any instructions provided here are in addition to the How to Apply - Application Guide instructions.

PHS Human Subjects and Clinical Trials Information (Overall) When involving human subjects research, clinical research, and/or NIH-defined clinical trials follow all instructions for the PHS Human Subjects and Clinical Trials Information form in the How to Apply - Application Guide, with the following additional instructions:

If you answered "Yes" to the question "Are Human Subjects Involved?" on the R&R Other Project Information form, there must be at least one human subjects study record using the Study Record: PHS Human Subjects and Clinical Trials Information form or a Delayed Onset Study record within the application. The study record(s) must be included in the component(s) where the work is being done, unless the same study spans multiple components. To avoid the creation of duplicate study records, a single study record with sufficient information for all involved components must be included in the Overall component when the same study spans multiple components.

Study Record: PHS Human Subjects and Clinical Trials Information All instructions in the How to Apply - Application Guide must be followed.

Delayed Onset Study

Note: Delayed onset does NOT apply to a study that can be described but will not start immediately (i.e., delayed start). All instructions in the How to Apply- Application Guide must be followed.

PHS Assignment Request Form (Overall) All instructions in the How to Apply- Application Guide must be followed.

Administrative Core When preparing your application, use Component Type 'Admin Core.' All instructions in the How to Apply- Application Guide must be followed, with the following additional instructions, as noted.

SF424 (R&R) Cover (Administrative Core) Complete only the following fields:

Applicant Information
Type of Applicant (optional)
Descriptive Title of Applicant's Project
Proposed Project Start/Ending Dates

PHS 398 Cover Page Supplement (Administrative Core) Enter Human Embryonic Stem Cells in each relevant component.

Research & Related Other Project Information (Administrative Core) Human Subjects: Answer only the 'Are Human Subjects Involved?' and 'Is the Project Exempt from Federal regulations?' questions.

Vertebrate Animals: Answer only the 'Are Vertebrate Animals Used?' question.

Project Narrative: Do not complete. Note: ASSIST screens will show an asterisk for this attachment indicating it is required. However, eRA systems only enforce this requirement in the Overall component and applications will not receive an error if omitted in other components.

Project/Performance Site Location(s) (Administrative Core) List all performance sites that apply to the specific component.

Note: The Project Performance Site form allows up to 300 sites, prior to using additional attachment for additional entries.

Research & Related Senior/Key Person Profile (Administrative Core)

In the Project Director/Principal Investigator section of the form, use Project Role of 'Other' with Category of 'Core Lead' and provide a valid eRA Commons ID in the Credential field.
In the additional Senior/Key Profiles section, list Senior/Key persons that are working in the component.
Include a single Biographical Sketch for each Senior/Key person listed in the application regardless of the number of components in which they participate. When a Senior/Key person is listed in multiple components, the Biographical Sketch can be included in any one component.
If more than 100 Senior/Key persons are included in a component, the Additional Senior Key Person attachments should be used.
The Administrative Core will be headed by the contact PD/PI of the application.
Within the Common Forms for Biographical Sketch and Current and Pending (Other) Support and NIH Biographical Sketch Supplement, highlight the experience, expertise, and ability of the Core lead and key personnel to manage all aspects of the Administrative Core.

Budget (Administrative Core) Budget forms appropriate for the specific component will be included in the application package.

Include costs for the following in the budget section:

Include funds to travel to two-day meetings: initial Kick-Off Meeting and to the Annual Programmatic Meeting for all Centers funded under this NOFO starting the second year of award. Each Center should fund travel and attendance at yearly meetings by the PD(s)/PI(s), the Project Leads, Core Leads, and other Key Personnel. These meetings are anticipated to be held at a location at/near Bethesda, Maryland or at another agreed-upon site following consultation with NIH staff. Travel and per diem costs to attend the initial Kick-Off Meeting and Annual Programmatic Meeting must be included in the budget; costs associated with organizing the Annual Programmatic Meeting are not allowable expenses.

Funds for the overall administrative efforts for the outreach activities should be requested beginning in year 2.

The Core Lead must commit at least 0.6 person-months effort to the Administrative Core.

Funds for personnel to participate in Program-wide working groups (e.g., Data Dissemination Working Groups, Modeling Working Groups, cross-center workshops) should be requested for each year.

For SBI Centers, the budget must include a single line item for Opportunities Funds on the Other Direct Costs category of the Administrative Core. This cost must not exceed $2 million in direct costs/year in years 2-5 to support one to six Collaborative Projects per year.

Note: The R&R Budget form included in many of the component types allows for up to 100 Senior/Key Persons in section A and 100 Equipment Items in section C prior to using attachments for additional entries. All other SF424 (R&R) instructions apply.

PHS 398 Research Plan (Administrative Core) Specific Aims: Briefly describe the broad objectives and goals and the proposed activities and services of the proposed Administrative Core.

Research Strategy: Describe plans and procedures for establishing and effectively managing an Administrative Core that provides the organizational and administrative capacity to ensure the following:

Managing, coordinating, and supervising the entire range of Center activities; monitoring progress; and ensuring that the overall project management plan is implemented effectively and within proposed timelines, which includes sponsoring activities to advance the Center's activities and goals.
Communicating and collaborating with the Project Scientist, Program Officer or other NIH staff.
Assisting other Cores and Research Project Leaders with administrative aspects of their projects, such as gathering of annual progress reports, monitoring progress and facilitating other communications with award recipients.
Communicating with other Centers regarding collaboration and coordination of activities and projects.
Ensuring the rapid dissemination of all data and other research resources generated under the Center.
Ensuring that there are representatives for all Consortium-wide activities (e.g. working groups) including adoption of new technologies, harmonization of protocols and data standards and establishing guidelines for presentation and publication of the results of cross-functional projects.
Ensuring outreach activities and engagement of new collaborators and instructional activities that promote use of datasets and resources resulting from the Center.

Management and Staffing Plan:

Describe how the organization of the Center and its management structure will form a cohesive Center that provides scientific and administrative oversight of all Center Cores and Research Projects.
Provide an overview of how the Research Projects will be coordinated, integrated, and scientifically and technically managed to answer the scientific questions and hypotheses proposed within the application and within the scope of the NOFO.
Describe the structure and roles of the administrative and scientific staff.

For CIDSB only: Outreach Activities Plan Describe outreach activities that will inform researchers about the approaches and resources (datasets, analysis tools, predictive models) utilized and generated under this initiative and promote collaborations with the pertinent scientific communities.

For SBI only: Opportunities Funds for Collaborative Projects Plan

Provide a plan to administer the SBI Opportunities Funds to support 1 – 6 Collaborative Projects starting in year 2.
Describe in detail how the Core will solicit, review, and manage collaboration requests from external researchers for Collaborative Projects.
Describe the team plans for disbursing and tracking SBI Opportunities Funds.
Outline how Collaborative Project funding decisions will be made in consultation with NIH staff.

Letters of Support: Provide letters of support for the leadership qualifications and experience of the Administrative Core leaders. Provide a letter of support from the applicant institution stating the commitment to administering the funds as described in the Opportunities Funds for Collaborative Projects Plan if selected by the NIH.

Resource Sharing Plan: Individuals are required to comply with the instructions for the Resource Sharing Plans as provided in the How to Apply- Application Guide.

Other Plan(s):

All instructions in the How to Apply - Application Guide must be followed, with the following additional instructions:

Do not include a Data Management and Sharing (DMS) Plan within this Component. If a DMS Plan is required for this NOFO, it must be included within the Overall Component.

Appendix:

Only limited items are allowed in the Appendix. Follow all instructions for the How to Apply- Application Guide; any instructions provided here are in addition to those in the How to Apply- Application Guide instructions.

PHS Human Subjects and Clinical Trials Information (Administrative Core) When involving human subjects research, clinical research, and/or NIH-defined clinical trials follow all instructions for the PHS Human Subjects and Clinical Trials Information form in the How to Apply- Application Guide, with the following additional instructions:

If you answered "Yes" to the question "Are Human Subjects Involved?" on the R&R Other Project Information form, you must include at least one human subjects study record using the Study Record: PHS Human Subjects and Clinical Trials Information form or a Delayed Onset Study record.

Study Record: PHS Human Subjects and Clinical Trials Information All instructions in the How to Apply- Application Guide must be followed.

Delayed Onset Study Note: Delayed onset does NOT apply to a study that can be described but will not start immediately (i.e., delayed start). All instructions in the How to Apply- Application Guide must be followed.

Data and Modeling Core When preparing your application, use Component Type 'DM Core.' All instructions in the How to Apply- Application Guide must be followed, with the following additional instructions, as noted.

SF424 (R&R) Cover (Data and Modeling Core) Complete only the following fields:

Applicant Information
Type of Applicant (optional)
Descriptive Title of Applicant's Project
Proposed Project Start/Ending Dates

PHS 398 Cover Page Supplement (Data and Modeling Core) Enter Human Embryonic Stem Cells in each relevant component.

Research & Related Other Project Information (Data and Modeling Core) Human Subjects: Answer only the 'Are Human Subjects Involved?' and 'Is the Project Exempt from Federal regulations?' questions.

Vertebrate Animals: Answer only the 'Are Vertebrate Animals Used?' question.

Project Narrative: Do not complete. Note: ASSIST screens will show an asterisk for this attachment indicating it is required. However, eRA systems only enforce this requirement in the Overall component and applications will not receive an error if omitted in other components.

Project/Performance Site Location(s) (Data and Modeling Core) List all performance sites that apply to the specific component.

Note: The Project Performance Site form allows up to 300 sites, prior to using additional attachment for additional entries.

Research & Related Senior/Key Person Profile (Data and Modeling Core)

In the Project Director/Principal Investigator section of the form, use Project Role of 'Other' with Category of 'Core Lead' and provide a valid eRA Commons ID in the Credential field.
In the additional Senior/Key Profiles section, list Senior/Key persons that are working in the component.
Include a single Biographical Sketch for each Senior/Key person listed in the application regardless of the number of components in which they participate. When a Senior/Key person is listed in multiple components, the Biographical Sketch can be included in any one component.
If more than 100 Senior/Key persons are included in a component, the Additional Senior Key Person attachments should be used.
Within the Common Forms for Biographical Sketch and Current and Pending (Other) Support and NIH Biographical Sketch Supplement, highlight the experience, expertise, and ability of the Core Lead and key personnel to manage all aspects of the Core.

Budget (Data and Modeling Core) Budget forms appropriate for the specific component will be included in the application package.

Include the following:

Funds to support central data storage, data processing, data use, and information security systems for the Center; and to support the submission of data, data analyses, and bioinformatics/computational tools to NIH approved databases, or other databases designated by NIH.
Funds to support the submission of the predictive models and computational/statistical tools to NIH approved databases, or other databases designated by NIH.
Funds to support the development, validation, and implementation of computational and statistical tools, machine learning algorithms, and statistical methods necessary for all aspects of building predictive models.
The Core Lead must commit at least 0.6 person-months effort to the Core.

Note: The R&R Budget form included in many of the component types allows for up to 100 Senior/Key Persons in section A and 100 Equipment Items in section C prior to using attachments for additional entries. All other SF424 (R&R) instructions apply.

PHS 398 Research Plan (Data and Modeling Core) Specific Aims: Briefly describe the broad objectives and goals and the proposed activities and services of the proposed Data and Modeling Core.

Research Strategy: Describe plans and procedures for establishing and effectively managing a Data and Modeling Core. Include the following:

Core Strategy and Alignment with Center GoalsDescribe how the Core's activities will advance the overall goals of the Center and justify the methods and approaches used to achieve its aims.
Explain how the Core's modeling framework will enable iterative application, validation, and refinement of predictive models.
Describe how the Core will contribute to Research Project experimental design, data integration, and predictive model development.
Data Stewardship and InfrastructureDescribe plans to establish processes for data stewardship, sample tracking, and monitoring of Center and collaborator activities.
Describe plans to develop and maintain a public website to share information about the Center and its resources, including datasets, predictive models, and reagents.
Describe methods and approaches for structuring, annotating, harmonizing, documenting, and integrating data, metadata, computational workflows, code, and predictive models to support interoperability, reuse, reproducibility, and AI-readiness across NIH-relevant platforms and resources, including the NIAID Data Ecosystem (for CIDSB Centers).
Methods Development and Predictive ModelingDescribe plans to develop and maintain state-of-art and innovative bioinformatics, computational, machine learning, and statistical methods for systems-level analysis of Research Project datasets, with the goal of generating predictive models that increase efficiency and precision.
Describe how relevant non-omics data–including behavioral, clinical, EHR, drug susceptibility, surveillance, environmental, and immunological data–will be incorporated into predictive models.
Collaboration, Community EngagementDescribe plans to collaborate with other Centers to develop and validate new methods, software, and approaches for infectious disease modeling.
Describe plans to develop SOPs, protocols, and analytical methods for dissemination to the broader scientific community.
Describe how the Core will draw on data from the Research Projects and other sources, to model host–pathogen, microbiome and inflammation interactions and dynamics.
Describe how the Core will support study design through statistical and computational expertise and ensure that resulting models are publicly available and suitable for clinically relevant applications.
Describe how the Core will develop new and improved bioinformatics tools.
Describe innovative mathematical modelling and computational method development to link different omics modalities and define functionalities, including a uniform pipeline for single-cell datasets to minimize reprocessing of data across the Consortium, approaches to standardize production of datasets that are AI-ready and secure workspaces for AI analyses, and computational pipelines and workflows enabling systematic integration of datasets into pathways.

This is the start of the file's text. The full file is on GovTribe.

Other files

File Type Posted
PKG00294514.pdf PDF

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

File details come from the government source that posted it. Updated .